3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphatic Abnormalities
2
Lymphangioma, Cystic
2
Lymphangioma
2
Vascular Malformations
1
Triple Negative Breast Neoplasms
1
Skin Diseases, Vascular
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Hyperglycemia
1
HER2-positive Metastatic Breast Cancer
1
Genetic Diseases, Inborn
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Arteriovenous Malformations
1
Advanced HER2+Breast Cancer
1
Advanced Breast Cancer
1
Interventions
Fulvestrant
4
ribociclib
2
palbociclib
2
Irinotecan
2
Gemcitabine
2
venetoclax
1
tivozanib
1
serabelisib
1
sapanisertib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
cemiplimab
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
STX-478
1
Paclitaxel
1
Metformin
1
Lomustine
1
Letrozole
1
Imlunestrant
1
Doxorubicin
1
Cetuximab
1
Carboplatin
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
Alpelisib
×
90 days
×
Clear all
No trials found.